NATIONAL HEALTHCARE CORP
Qualité des données : 100%
NHC
NYSE
Services
Health Services
170,85 €
▼
5,96 €
(-3,37%)
Cap. Boursière: 2,76 B
Prix
177,22 €
Cap. Boursière
2,76 B
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 9,02% annually over 5 years — modest growth
Earnings grew 17,75% over the past year
ROE of 11,57% — decent returns on equity
Debt/Equity of 0,07 — conservative balance sheet
Generating 148,63 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,07%
Croissance
Revenue Growth (5Y)
9,02%
Au-dessus de la moyenne du secteur (4,21%)
Revenue (1Y)16,09%
Earnings (1Y)17,75%
FCF Growth (3Y)33,57%
Qualité
Return on Equity
11,57%
Au-dessus de la moyenne du secteur (-15,95%)
ROIC7,50%
Net Margin7,91%
Op. Margin8,46%
Sécurité
Debt / Equity
0,07
En dessous de la moyenne du secteur (0,39)
Current Ratio1,75
Interest Coverage20,15
Valorisation
PE (TTM)
23,03
Au-dessus de la moyenne du secteur (-1,17)
P/B Ratio2,63
EV/EBITDA15,62
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Services (502 pairs)
Comparaison Sectorielle
vs médiane du secteur Services (502 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,0 | -1,2 |
| P/B | 2,6 | 1,4 |
| ROE % | 11,6 | -16,0 |
| Net Margin % | 7,9 | -18,3 |
| Rev Growth 5Y % | 9,0 | 4,2 |
| D/E | 0,1 | 0,4 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
Surprises de Résultats
Dernier 1 trimestre
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q22021 | N/A | 6,80 € | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,09% | Revenue Growth (3Y) | 15,31% |
| Earnings Growth (1Y) | 17,75% | Earnings Growth (3Y) | 34,04% |
| Revenue Growth (5Y) | 9,02% | Earnings Growth (5Y) | -3,53% |
| Profitability | |||
| Revenue (TTM) | 1,52 B | Net Income (TTM) | 120,02 M |
| ROE | 11,57% | ROA | 7,66% |
| Gross Margin | N/A | Operating Margin | 8,46% |
| Net Margin | 7,91% | Free Cash Flow (TTM) | 148,63 M |
| ROIC | 7,50% | FCF Growth (3Y) | 33,57% |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 1,75 |
| Interest Coverage | 20,15 | Asset Turnover | 0,97 |
| Working Capital | 211,16 M | Tangible Book Value | 862,64 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 23,03 | Forward P/E | N/A |
| P/B Ratio | 2,63 | P/S Ratio | 1,82 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 15,62 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 5,38% | ||
| Market Cap | 2,76 B | Enterprise Value | 2,71 B |
| Per Share | |||
| EPS (Diluted TTM) | 7,67 | Revenue / Share | 97,30 |
| FCF / Share | 9,53 | OCF / Share | 11,86 |
| EPS CAGR (1Y) | 17,46% | EPS CAGR (5Y) | -3,89% |
| EPS CAGR (10Y) | 9,75% | ||
| Efficiency | |||
| CapEx / Revenue | 2,40% | FCF Conversion | 123,84% |
| SBC-Adj. FCF | 144,04 M | Growth Momentum | 7,07 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,52 B | 1,31 B | 1,14 B | 1,09 B | 1,07 B |
| Net Income | 120,02 M | 101,93 M | 66,80 M | 22,45 M | 138,59 M |
| EPS (Diluted) | 7,67 | 6,53 | 4,34 | 1,45 | 8,99 |
| Gross Profit | — | — | — | — | — |
| Operating Income | 128,35 M | 85,76 M | 57,13 M | 31,90 M | 50,93 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 44,92 M | 41,99 M | 42,03 M | 40,49 M | 40,67 M |
| Interest Expense | 6,37 M | 4,14 M | 324 000,0 | 563 000,0 | 845 000,0 |
| Income Tax | 39,83 M | 34,32 M | 23,45 M | 7,25 M | 10,95 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,53 B | 1,52 B | 1,31 B | 1,28 B | 1,40 B |
| Total Liabilities | 451,90 M | 541,27 M | 400,32 M | 397,94 M | 494,94 M |
| Shareholders' Equity | 1,07 B | 980,16 M | 908,75 M | 874,28 M | 903,00 M |
| Total Debt | 40,00 M | 137,00 M | — | — | — |
| Cash & Equivalents | 92,83 M | 76,12 M | 107,08 M | 58,67 M | 107,61 M |
| Current Assets | 461,82 M | 424,41 M | 406,24 M | 353,93 M | 426,64 M |
| Current Liabilities | 253,63 M | 234,80 M | 214,48 M | 197,89 M | 263,20 M |
{"event":"ticker_viewed","properties":{"ticker":"NHC","listing_kind":"stock","pathname":"/stocks/nhc","exchange":"NYSE","country":"US"}}


